Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statins and clinical outcomes in hospitalized COVID-19 patients with and without Diabetes Mellitus: a retrospective cohort study with propensity score matching
Prateek Lohia, Shweta Kapur, Sindhuri Benjaram, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 24

Showing 24 citing articles:

Lipid Raft Integrity and Cellular Cholesterol Homeostasis Are Critical for SARS-CoV-2 Entry into Cells
Ahmed Bakillah, Fatimah Al Hejji, Abdulrahman Almasaud, et al.
Nutrients (2022) Vol. 14, Iss. 16, pp. 3417-3417
Open Access | Times Cited: 41
Association of Statins for Primary Prevention of Cardiovascular Diseases With Hospitalization for COVID‐19: A Nationwide Matched Population‐Based Cohort Study
Kim Bouillon, Bérangère Baricault, Laura Semenzato, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 12
Open Access | Times Cited: 19
Novel progression on clinical therapy of COVID-19: Western and Traditional Chinese Medicines
Yongjia Xiong, Yun Li, Feiyue Xing
(2025)
Open Access
Ongoing Use of SSRIs Does Not Alter Outcome in Hospitalized COVID-19 Patients: A Retrospective Analysis
Steven H. Rauchman, Sherri Mendelson, Courtney Rauchman, et al.
Journal of Clinical Medicine (2021) Vol. 11, Iss. 1, pp. 70-70
Open Access | Times Cited: 18
Discontinuation of atorvastatin use in hospital is associated with increased risk of mortality in COVID‐19 patients
Laura Andrews, Laurel Goldin, Yan Shen, et al.
Journal of Hospital Medicine (2022) Vol. 17, Iss. 3, pp. 169-175
Open Access | Times Cited: 12
The Effects of Statins on Respiratory Symptoms and Pulmonary Fibrosis in COVID-19 Patients with Diabetes Mellitus: A Longitudinal Multicenter Study
Mohammadamin Sadeghdoust, Farnaz Aligolighasemabadi, Tania Dehesh, et al.
Archivum Immunologiae et Therapiae Experimentalis (2023) Vol. 71, Iss. 1
Open Access | Times Cited: 7
Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy
Vyoma Snehal Trivedi, Albert Frank Magnusen, Reena Rani, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14340-14340
Open Access | Times Cited: 11
The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19)
Gemma Llauradó, Bogdan Vlacho, Matthieu Wargny, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 10
The association between statin and COVID-19 adverse outcomes: national COVID-19 cohort in South Korea
Ronald Chow, Jihui Lee, Hyerim Noh, et al.
Annals of Palliative Medicine (2022) Vol. 11, Iss. 4, pp. 1297-1307
Open Access | Times Cited: 9
Relative contributions of statin intensity, achieved low-density lipoprotein cholesterol level, and statin therapy duration to cardiovascular risk reduction in patients with type 2 diabetes: population based cohort study
Ji Yoon Kim, Jimi Choi, Sin Gon Kim, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 8
Association of statin and/or renin-angiotensin-aldosterone system modulating therapy with mortality in adults with diabetes admitted to hospital with COVID-19: A retrospective multicentre European study
Sophie Harris, Yue Ruan, Sarah H. Wild, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 16, Iss. 5, pp. 102484-102484
Open Access | Times Cited: 7
Treating COVID-19: Targeting the Host Response, Not the Virus
David S. Fedson
Life (2023) Vol. 13, Iss. 3, pp. 712-712
Open Access | Times Cited: 4
Impact of Statin or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker on In-Hospital Mortality of COVID-19 Patients
Mohsen Gholinataj Jelodar, Samaneh Mirzaei, Majid Haji Maghsoudi
Journal of Pharmaceutical Care (2024)
Open Access | Times Cited: 1
Association of early statin initiation during COVID-19 admission with inpatient mortality at an academic health system in Illinois, March 2020 to September 2022: a target trial emulation using observational data
Adovich S. Rivera, Omar Al-Heeti, Matthew J. Feinstein, et al.
BMJ Open (2024) Vol. 14, Iss. 10, pp. e085547-e085547
Open Access | Times Cited: 1
Influence of glimepiride plus sitagliptin on treatment outcome, blood glucose, and oxidative stress in diabetic patients.
Xiaoqin Zhao, Ping Huang, Jie Yuan
PubMed (2022) Vol. 14, Iss. 10, pp. 7459-7466
Closed Access | Times Cited: 3
Statin use and clinical outcomes in hospitalized COVID-19 patients
Khalid Saud Alshaalan, Rahaf F. Alkahtani, Renad Althobaiti, et al.
Saudi Medical Journal (2024) Vol. 45, Iss. 2, pp. 171-178
Open Access
Ongoing use of SSRIs and the hospital course of COVID-19 patients: a retrospective outcome analysis
Steven H. Rauchman, Sherri Mendelson, Courtney Rauchman, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Real world data on cardiometabolic diseases in U.S. adults during the SARS-CoV-2 pandemic: a decentralized registry study
Parth Shah, Kim Magee, Kiara H. Buccellato, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Circulating Lipids and COVID-19: Insights From Mendelian Randomization
Michael G. Levin
Arteriosclerosis Thrombosis and Vascular Biology (2021) Vol. 41, Iss. 11, pp. 2811-2813
Open Access | Times Cited: 1
HUBUNGAN MANFAAT PENGGUNAAN STATIN PADA PASIEN CORONAVIRUS DISEASE 2019 (COVID-19): SEBUAH REVIEW
Arsenila Dewi Pramanti, Melisa Intan Barliana, Keri Lestari
Jurnal Ilmiah Farmako Bahari (2023) Vol. 14, Iss. 1, pp. 66-66
Open Access
The Role of Diabetes on the mortality rate of Patients with COVID-19: A systematic review
Forough Saki, Marzieh Nemati, Bahareh Ebrahimi, et al.
Research Square (Research Square) (2023)
Open Access
Effect of Statin on Mortality in Diabetic Patients with COVID-19: A Systematic Review and Meta-Analysis
Azin Alizadehasl, Davood Khoda Amorzideh, Nashmil Ghadimi, et al.
Research in Cardiovascular Medicine (2023) Vol. 12, Iss. 1, pp. 1-7
Open Access
Atorvastatin: old friend in the light of novel coronavirus infection’s pandemia
М. В. Ежов, Т. Е. Колмакова, М. А. Матвеева, et al.
Meditsinskiy sovet = Medical Council (2022), Iss. 4, pp. 82-88
Open Access
Statins and COVID-19: emerging evidence on the safety and efficacy of statins in COVID-19
Shweta Kapur, Prateek Lohia
Annals of Palliative Medicine (2022) Vol. 11, Iss. 4, pp. 1157-1159
Open Access
Page 1

Scroll to top